Dierenartsen Hond en Kat SRL
Dierenartsen Hond en Kat reported total assets of 321,318 € at the end of the 2024 financial year (annual accounts filed with the NBB on 07 Nov 2025).
The score of Dierenartsen Hond en Kat shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +6 % Total assets +34 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dierenartsen Hond en Kat's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 07 Nov 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 22 May 2023
- Year ended 31 Dec 2021filed on 12 May 2022
Dierenartsen Hond en Kat's financial analysis
- Solvency0.7%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dierenartsen Hond en Kat
Dierenartsen Hond en Kat's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0758.615.818
- VAT number
- BE0758615818
- Peppol
- Registered · 0208:0758615818 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Nov 2020
- Registered office
- 9800 Deinze
- Latest accounts
- 2024 · filed on 07 Nov 2025
- Activity
- Manufacture of medicaments (NACE 21201)
Dierenartsen Hond en Kat (SRL) has been based in Deinze since 2020, active in: manufacture of medicaments. For 2024, it reports a net profit of 57,626 € and equity of 2,114 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dierenartsen Hond en Kat
Companies in the same business, of comparable size and area, outside its group.
- Orthophar Manufacture of pharmaceutical preparations Kortrijk · balance sheet 258,756 €
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Oropharma Manufacture of pharmaceutical preparations Deinze · balance sheet 352,437 €
- Apotheek Vanderhaeghen Marc Retail sale of pharmaceutical products Bruges · balance sheet 394,045 €
- Nutrirepair Activities of agents involved in non-specialised wholesale Uccle · balance sheet 7,775 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- DJB Medical Wholesale of pharmaceutical and medical goods Merchtem · balance sheet 406,739 €
Frequently asked questions about Dierenartsen Hond en Kat
What is the revenue of Dierenartsen Hond en Kat?
Dierenartsen Hond en Kat files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Dierenartsen Hond en Kat?
In Belgium, the VAT number is the company number prefixed with BE: BE0758615818 for Dierenartsen Hond en Kat, if the company is VAT-registered. Its company number (CBE) is 0758.615.818.
Where is the registered office of Dierenartsen Hond en Kat?
According to the CBE register, the registered office of Dierenartsen Hond en Kat is in 9800 Deinze.
What is the equity of Dierenartsen Hond en Kat?
At the close of the 2024 financial year, the equity of Dierenartsen Hond en Kat amounts to 2,114 €, a solvency of 0.7% of total assets.
Who manages Dierenartsen Hond en Kat?
The register lists 4 active mandates at Dierenartsen Hond en Kat. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dierenartsen Hond en Kat
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →